Walmart Stores Avaphinal Maximum Male Enhancement Sexual Recall

Why it was recalled

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Product description

Avaphinal Maximum Male Enhancement Sexual Pills, 2000 MG*, packaged in 10 Capsules per carton.

Lot numbers, UPCs & expiration codes

Lot: DK1027, Exp 08/01/2023

Where it was sold

Nationwide in the USA via www.walmart.com

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0725-2022
Classification: Class I
Status: Terminated
Recall initiated: Feb 9, 2022
FDA report date: Mar 23, 2022
Quantity: unknown
Recall type: Voluntary: Firm initiated
Recalling firm: Walmart Stores

Original FDA data

Every field from FDA enforcement report D-0725-2022, exactly as published.

Show all FDA fields

City: Bentonville
State: AR
Status: Terminated
Country: United States
Event ID: 89686
Address: 805 Moberly Ln
Code information: Lot: DK1027, Exp 08/01/2023
Postal code: 72716-0560
Report date: Mar 23, 2022
Product type: Drugs
Recall number: D-0725-2022
Classification: Class I
Recalling firm: Walmart Stores
Product quantity: unknown
Termination date: Dec 2, 2022
Reason for recall: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Avaphinal Maximum Male Enhancement Sexual Pills, 2000 MG*, packaged in 10 Capsules per carton.
Distribution pattern: Nationwide in the USA via www.walmart.com
Recall initiation date: Feb 9, 2022
Initial firm notification: E-Mail
Center classification date: Mar 29, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0725-2022, published Mar 23, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.